drugset / Trial / NCT03801629

Neuroimmune Effects of Opioid Administration

NCT03801629

Phase 1 Completed 10 enrolled Yale University
Non-randomizedParallel-groupSingle-blindBasic science

Summary

Preclinical research indicates acute opioid administration evokes an immune response in the periphery and brain. Here, we will translate those preclinical findings to healthy human volunteers and quantify the neuroimmune response to a morphine challenge using positron emission tomography (PET) imaging with \[11C\]PBR28.

Timeline

Start
2019-09-12
Primary completion
2021-03-10
Completion
2021-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 0.04 mg/kg Intramuscular
Subject Morphine Other / unclassified 0.07 mg/kg Intramuscular
Background Metoclopramide Small molecule 10 mg Oral

Indications

No indication recorded.